AAAAAA
Results:
1-14
|
Results: 14
Authors:
Celis, E
Citation: E. Celis, Identification and selection of T-cell epitopes derived from tumor-associated antigens for the development of immunotherapy for cancer, MED INTEL U, 24, 2000, pp. 1-16
Authors:
Maher, VE
Worley, BS
Contois, D
Smith, MC
Kelley, MJ
Stipanov, M
Khleif, SN
Goletz, T
van den Broeke, L
Mackall, C
Helman, LJ
Carbone, DP
Berzofsky, JA
Citation: Ve. Maher et al., Mutant oncogene and tumor suppressor gene products and fusion proteins created by chromosomal translocations as targets for cancer vaccines, MED INTEL U, 24, 2000, pp. 17-39
Authors:
Vierboom, MPM
Gabrilovich, DI
Offringa, R
Kast, WM
Melief, CJM
Citation: Mpm. Vierboom et al., p53: A target for T-cell mediated immunotherapy, MED INTEL U, 24, 2000, pp. 40-55
Authors:
Holt, GE
Velders, MP
Rudolf, MP
Small, LA
Provenzano, M
Weijzen, S
Da Silva, DM
Visser, M
ter Horst, SAJ
Brandt, RMP
Kast, WM
Citation: Ge. Holt et al., Critical dependence of the peptide delivery method on the efficacy of epitope focused immunotherapy, MED INTEL U, 24, 2000, pp. 56-72
Authors:
Weber, JS
Citation: Js. Weber, Cancer peptide vaccines in clinical trials, MED INTEL U, 24, 2000, pp. 73-89
Authors:
Schlom, J
Citation: J. Schlom, Carcinoembryonic antigen (CEA) peptides and vaccines for carcinoma, MED INTEL U, 24, 2000, pp. 90-105
Authors:
Apostolopoulos, V
Pietersz, GA
McKenzie, IFC
Citation: V. Apostolopoulos et al., Studies of MUC1 peptides, MED INTEL U, 24, 2000, pp. 106-120
Authors:
Seliger, B
Kono, K
Rongcun, Y
Kiessling, R
Citation: B. Seliger et al., Cytotoxic T cell epitopes and tissue distribution of the HER-2/neu proto-oncogene: Implications for vaccine development, MED INTEL U, 24, 2000, pp. 121-142
Authors:
Disis, ML
Cheever, MA
Citation: Ml. Disis et Ma. Cheever, Clinical trials of HER-2/neu peptide-based vaccines, MED INTEL U, 24, 2000, pp. 143-154
Authors:
Salgaller, ML
Citation: Ml. Salgaller, Peptides in prostate cancer, MED INTEL U, 24, 2000, pp. 155-171
Authors:
Ressing, ME
Brandt, RMP
de Jong, JH
Offringa, R
Melief, CJM
Kast, WM
Citation: Me. Ressing et al., Peptides in cervical cancer, MED INTEL U, 24, 2000, pp. 172-189
Authors:
Overwijk, WW
Restifo, NP
Citation: Ww. Overwijk et Np. Restifo, Peptide vaccines for the treatment of melanoma, MED INTEL U, 24, 2000, pp. 190-199
Authors:
Vissers, JLM
de Vries, IJM
Oosterwijk, E
Figdor, CG
Adema, GJ
Citation: Jlm. Vissers et al., Gp100 and G250: Towards specific immunotherapy employing dendritic cells in melanoma and renal cell carcinoma, MED INTEL U, 24, 2000, pp. 200-214
Authors:
Davis, ID
Lotze, MT
Citation: Id. Davis et Mt. Lotze, Melanoma peptide clinical trials, MED INTEL U, 24, 2000, pp. 215-236
Risultati:
1-14
|